How Robotics Is Reshaping Life Sciences - Ira Hoffman, HighRes Biosolutions CEO; Carla Reimold, Massachusetts Life Sciences Center EVP of scientific innovation and strategic investments; Dave Johnson, Dash Bio founder & CEO; and Rajit Kamal, Medtronic Surgical Robotics VP & GM; moderated by Brian Gormley, Wall Street Journal special writer.
The panel discussed using sensors to improve perception and precision, the necessity of end user testing and approval, improved ergonomics and teleoperation potential of robotic surgery, modularity and adaptability for small batch medicine production, and the application of AI to create automation-friendly laboratory protocols along with personalized patient care. All these changes can help democratize access to medicine and medical care.
Photo by Donald Halsing | Peerless Media
Edge computing gives AI agents the processing power to turn instructions into…
Daimon-TWM world model debuts for the public
Platform helps robots adapt to complex tasks
Look beyond the headlines for the latest in humanoid robots
